The Procter & Gamble Company Logo

The Procter & Gamble Company

PG

(3.2)
Stock Price

169,54 USD

24.79% ROA

30.28% ROE

26.64x PER

Market Cap.

395.127.233.600,00 USD

65.03% DER

2.32% Yield

17.71% NPM

The Procter & Gamble Company Stock Analysis

The Procter & Gamble Company Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

The Procter & Gamble Company Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (32.96%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

4 Dividend Growth

Investors can be encouraged by the company's strong dividend growth over the past five years, highlighting its ability to generate consistent returns and provide an attractive investment opportunity.

5 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

6 DER

The stock has a reasonable amount of debt compared to its ownership (75%), suggesting a balanced financial position and a moderate level of risk.

7 Assets Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

8 Buffet Intrinsic Value

The company's stock seems undervalued (913) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

9 PBV

The stock's high Price-to-Book Value (P/BV) ratio (7.48x) suggests it's overvalued, potentially making it an expensive investment.

10 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

11 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

The Procter & Gamble Company Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

The Procter & Gamble Company Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

The Procter & Gamble Company Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

The Procter & Gamble Company Revenue
Year Revenue Growth
1986 15.439.000.000
1987 17.000.000.000 9.18%
1988 19.336.000.000 12.08%
1989 21.398.000.000 9.64%
1990 24.081.000.000 11.14%
1991 27.026.000.000 10.9%
1992 29.362.000.000 7.96%
1993 30.433.000.000 3.52%
1994 30.296.000.000 -0.45%
1995 33.434.000.000 9.39%
1996 35.284.000.000 5.24%
1997 35.764.000.000 1.34%
1998 37.154.000.000 3.74%
1999 38.125.000.000 2.55%
2000 39.951.000.000 4.57%
2001 39.244.000.000 -1.8%
2002 40.238.000.000 2.47%
2003 43.377.000.000 7.24%
2004 51.407.000.000 15.62%
2005 56.741.000.000 9.4%
2006 68.222.000.000 16.83%
2007 76.476.000.000 10.79%
2008 83.503.000.000 8.42%
2009 76.694.000.000 -8.88%
2010 78.938.000.000 2.84%
2011 82.559.000.000 4.39%
2012 83.680.000.000 1.34%
2013 84.167.000.000 0.58%
2014 83.062.000.000 -1.33%
2015 76.279.000.000 -8.89%
2016 65.299.000.000 -16.81%
2017 65.058.000.000 -0.37%
2018 66.832.000.000 2.65%
2019 67.684.000.000 1.26%
2020 70.950.000.000 4.6%
2021 76.118.000.000 6.79%
2022 80.187.000.000 5.07%
2023 82.006.000.000 2.22%
2024 82.128.000.000 0.15%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

The Procter & Gamble Company Research and Development Expenses
Year Research and Development Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 1.940.000.000 100%
2014 1.910.000.000 -1.57%
2015 1.991.000.000 4.07%
2016 1.879.000.000 -5.96%
2017 1.874.000.000 -0.27%
2018 1.908.000.000 1.78%
2019 1.861.000.000 -2.53%
2020 1.800.000.000 -3.39%
2021 1.900.000.000 5.26%
2022 2.000.000.000 5%
2023 2.000.000.000 0%
2024 8.000.000.000 75%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

The Procter & Gamble Company General and Administrative Expenses
Year General and Administrative Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 9.361.000.000 100%
1995 9.632.000.000 2.81%
1996 9.707.000.000 0.77%
1997 9.960.000.000 2.54%
1998 10.035.000.000 0.75%
1999 10.666.000.000 5.92%
2000 12.483.000.000 14.56%
2001 12.406.000.000 -0.62%
2002 12.571.000.000 1.31%
2003 13.383.000.000 6.07%
2004 16.504.000.000 18.91%
2005 18.010.000.000 8.36%
2006 21.848.000.000 17.57%
2007 24.340.000.000 10.24%
2008 25.725.000.000 5.38%
2009 24.008.000.000 -7.15%
2010 24.998.000.000 3.96%
2011 25.973.000.000 3.75%
2012 26.421.000.000 1.7%
2013 26.950.000.000 1.96%
2014 25.314.000.000 -6.46%
2015 23.585.000.000 -7.33%
2016 18.949.000.000 -24.47%
2017 18.568.000.000 -2.05%
2018 18.853.000.000 1.51%
2019 12.284.000.000 -53.48%
2020 12.694.000.000 3.23%
2021 12.824.000.000 1.01%
2022 12.317.000.000 -4.12%
2023 13.112.000.000 6.06%
2024 -12.344.000.000 206.22%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

The Procter & Gamble Company EBITDA
Year EBITDA Growth
1986 1.669.000.000
1987 1.273.000.000 -31.11%
1988 2.338.000.000 45.55%
1989 2.515.000.000 7.04%
1990 2.600.000.000 3.27%
1991 3.278.000.000 20.68%
1992 3.390.000.000 3.3%
1993 1.151.000.000 -194.53%
1994 4.466.000.000 74.23%
1995 5.123.000.000 12.82%
1996 5.835.000.000 12.2%
1997 6.757.000.000 13.65%
1998 7.452.000.000 9.33%
1999 8.166.000.000 8.74%
2000 7.841.000.000 -4.14%
2001 6.333.000.000 -23.81%
2002 8.063.000.000 21.46%
2003 9.318.000.000 13.47%
2004 11.408.000.000 18.32%
2005 12.465.000.000 8.48%
2006 15.593.000.000 20.06%
2007 18.016.000.000 13.45%
2008 19.787.000.000 8.95%
2009 18.456.000.000 -7.21%
2010 19.129.000.000 3.52%
2011 18.656.000.000 -2.54%
2012 18.334.000.000 -1.76%
2013 18.800.000.000 2.48%
2014 18.735.000.000 -0.35%
2015 17.634.000.000 -6.24%
2016 17.026.000.000 -3.57%
2017 16.542.000.000 -2.93%
2018 16.666.000.000 0.74%
2019 17.747.000.000 6.09%
2020 19.312.000.000 8.1%
2021 20.852.000.000 7.39%
2022 21.241.000.000 1.83%
2023 21.823.000.000 2.67%
2024 17.724.000.000 -23.13%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

The Procter & Gamble Company Gross Profit
Year Gross Profit Growth
1986 6.101.000.000
1987 7.218.000.000 15.48%
1988 8.153.000.000 11.47%
1989 8.794.000.000 7.29%
1990 10.282.000.000 14.47%
1991 11.901.000.000 13.6%
1992 13.089.000.000 9.08%
1993 13.890.000.000 5.77%
1994 14.075.000.000 1.31%
1995 13.811.000.000 -1.91%
1996 14.522.000.000 4.9%
1997 15.448.000.000 5.99%
1998 16.090.000.000 3.99%
1999 16.919.000.000 4.9%
2000 18.437.000.000 8.23%
2001 17.142.000.000 -7.55%
2002 19.249.000.000 10.95%
2003 21.236.000.000 9.36%
2004 26.331.000.000 19.35%
2005 28.937.000.000 9.01%
2006 35.097.000.000 17.55%
2007 39.790.000.000 11.79%
2008 42.808.000.000 7.05%
2009 38.004.000.000 -12.64%
2010 41.019.000.000 7.35%
2011 41.791.000.000 1.85%
2012 41.289.000.000 -1.22%
2013 41.739.000.000 1.08%
2014 40.602.000.000 -2.8%
2015 37.403.000.000 -8.55%
2016 32.390.000.000 -15.48%
2017 32.523.000.000 0.41%
2018 32.400.000.000 -0.38%
2019 32.916.000.000 1.57%
2020 35.700.000.000 7.8%
2021 39.010.000.000 8.49%
2022 38.030.000.000 -2.58%
2023 39.246.000.000 3.1%
2024 40.736.000.000 3.66%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

The Procter & Gamble Company Net Profit
Year Net Profit Growth
1986 709.000.000
1987 327.000.000 -116.82%
1988 1.020.000.000 67.94%
1989 1.206.000.000 15.42%
1990 1.602.000.000 24.72%
1991 1.773.000.000 9.64%
1992 1.872.000.000 5.29%
1993 -656.000.000 385.37%
1994 2.211.000.000 129.67%
1995 2.645.000.000 16.41%
1996 3.046.000.000 13.16%
1997 3.415.000.000 10.81%
1998 3.780.000.000 9.66%
1999 3.763.000.000 -0.45%
2000 3.542.000.000 -6.24%
2001 2.922.000.000 -21.22%
2002 4.352.000.000 32.86%
2003 5.186.000.000 16.08%
2004 6.481.000.000 19.98%
2005 7.257.000.000 10.69%
2006 8.684.000.000 16.43%
2007 10.340.000.000 16.02%
2008 12.075.000.000 14.37%
2009 13.436.000.000 10.13%
2010 12.736.000.000 -5.5%
2011 11.797.000.000 -7.96%
2012 10.756.000.000 -9.68%
2013 11.312.000.000 4.92%
2014 11.643.000.000 2.84%
2015 7.036.000.000 -65.48%
2016 10.508.000.000 33.04%
2017 15.326.000.000 31.44%
2018 9.750.000.000 -57.19%
2019 3.897.000.000 -150.19%
2020 13.027.000.000 70.09%
2021 14.306.000.000 8.94%
2022 14.742.000.000 2.96%
2023 14.653.000.000 -0.61%
2024 12.548.000.000 -16.78%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

The Procter & Gamble Company Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 1 0%
1991 1 0%
1992 1 0%
1993 0 0%
1994 1 0%
1995 1 0%
1996 1 100%
1997 1 0%
1998 1 0%
1999 1 0%
2000 1 0%
2001 1 0%
2002 2 0%
2003 2 0%
2004 2 50%
2005 3 0%
2006 3 0%
2007 3 33.33%
2008 4 0%
2009 4 25%
2010 4 0%
2011 4 0%
2012 4 -33.33%
2013 4 25%
2014 4 0%
2015 3 -100%
2016 4 33.33%
2017 6 40%
2018 4 -66.67%
2019 2 -200%
2020 5 80%
2021 6 0%
2022 6 16.67%
2023 6 0%
2024 5 -20%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

The Procter & Gamble Company Free Cashflow
Year Free Cashflow Growth
1990 706.000.000
1991 90.000.000 -684.44%
1992 1.159.000.000 92.23%
1993 1.427.000.000 18.78%
1994 1.808.000.000 21.07%
1995 1.422.000.000 -27.14%
1996 1.979.000.000 28.15%
1997 3.753.000.000 47.27%
1998 2.326.000.000 -61.35%
1999 2.716.000.000 14.36%
2000 1.657.000.000 -63.91%
2001 3.318.000.000 50.06%
2002 6.063.000.000 45.27%
2003 7.218.000.000 16%
2004 7.338.000.000 1.64%
2005 6.541.000.000 -12.18%
2006 8.708.000.000 24.89%
2007 10.490.000.000 16.99%
2008 12.768.000.000 17.84%
2009 11.681.000.000 -9.31%
2010 13.005.000.000 10.18%
2011 9.925.000.000 -31.03%
2012 9.320.000.000 -6.49%
2013 10.865.000.000 14.22%
2014 10.110.000.000 -7.47%
2015 10.872.000.000 7.01%
2016 12.121.000.000 10.3%
2017 9.369.000.000 -29.37%
2018 11.150.000.000 15.97%
2019 11.895.000.000 6.26%
2020 14.330.000.000 16.99%
2021 15.584.000.000 8.05%
2022 13.567.000.000 -14.87%
2023 13.786.000.000 1.59%
2024 4.970.000.000 -177.38%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

The Procter & Gamble Company Operating Cashflow
Year Operating Cashflow Growth
1990 2.006.000.000
1991 2.069.000.000 3.04%
1992 3.070.000.000 32.61%
1993 3.338.000.000 8.03%
1994 3.649.000.000 8.52%
1995 3.568.000.000 -2.27%
1996 4.158.000.000 14.19%
1997 5.882.000.000 29.31%
1998 4.885.000.000 -20.41%
1999 5.544.000.000 11.89%
2000 4.675.000.000 -18.59%
2001 5.804.000.000 19.45%
2002 7.742.000.000 25.03%
2003 8.700.000.000 11.01%
2004 9.362.000.000 7.07%
2005 8.722.000.000 -7.34%
2006 11.375.000.000 23.32%
2007 13.435.000.000 15.33%
2008 15.814.000.000 15.04%
2009 14.919.000.000 -6%
2010 16.072.000.000 7.17%
2011 13.231.000.000 -21.47%
2012 13.284.000.000 0.4%
2013 14.873.000.000 10.68%
2014 13.958.000.000 -6.56%
2015 14.608.000.000 4.45%
2016 15.435.000.000 5.36%
2017 12.753.000.000 -21.03%
2018 14.867.000.000 14.22%
2019 15.242.000.000 2.46%
2020 17.403.000.000 12.42%
2021 18.371.000.000 5.27%
2022 16.723.000.000 -9.85%
2023 16.848.000.000 0.74%
2024 5.753.000.000 -192.86%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

The Procter & Gamble Company Capital Expenditure
Year Capital Expenditure Growth
1990 1.300.000.000
1991 1.979.000.000 34.31%
1992 1.911.000.000 -3.56%
1993 1.911.000.000 0%
1994 1.841.000.000 -3.8%
1995 2.146.000.000 14.21%
1996 2.179.000.000 1.51%
1997 2.129.000.000 -2.35%
1998 2.559.000.000 16.8%
1999 2.828.000.000 9.51%
2000 3.018.000.000 6.3%
2001 2.486.000.000 -21.4%
2002 1.679.000.000 -48.06%
2003 1.482.000.000 -13.29%
2004 2.024.000.000 26.78%
2005 2.181.000.000 7.2%
2006 2.667.000.000 18.22%
2007 2.945.000.000 9.44%
2008 3.046.000.000 3.32%
2009 3.238.000.000 5.93%
2010 3.067.000.000 -5.58%
2011 3.306.000.000 7.23%
2012 3.964.000.000 16.6%
2013 4.008.000.000 1.1%
2014 3.848.000.000 -4.16%
2015 3.736.000.000 -3%
2016 3.314.000.000 -12.73%
2017 3.384.000.000 2.07%
2018 3.717.000.000 8.96%
2019 3.347.000.000 -11.05%
2020 3.073.000.000 -8.92%
2021 2.787.000.000 -10.26%
2022 3.156.000.000 11.69%
2023 3.062.000.000 -3.07%
2024 783.000.000 -291.06%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

The Procter & Gamble Company Equity
Year Equity Growth
1986 5.704.000.000
1987 5.740.000.000 0.63%
1988 6.337.000.000 9.42%
1989 5.215.000.000 -21.51%
1990 7.518.000.000 30.63%
1991 7.736.000.000 2.82%
1992 9.071.000.000 14.72%
1993 7.441.000.000 -21.91%
1994 8.832.000.000 15.75%
1995 10.589.000.000 16.59%
1996 11.722.000.000 9.67%
1997 12.046.000.000 2.69%
1998 12.236.000.000 1.55%
1999 12.058.000.000 -1.48%
2000 12.287.000.000 1.86%
2001 12.010.000.000 -2.31%
2002 13.706.000.000 12.37%
2003 16.186.000.000 15.32%
2004 17.278.000.000 6.32%
2005 17.477.000.000 1.14%
2006 62.908.000.000 72.22%
2007 66.760.000.000 5.77%
2008 69.494.000.000 3.93%
2009 63.382.000.000 -9.64%
2010 61.763.000.000 -2.62%
2011 68.001.000.000 9.17%
2012 64.631.000.000 -5.21%
2013 69.354.000.000 6.81%
2014 70.738.000.000 1.96%
2015 63.681.000.000 -11.08%
2016 58.625.000.000 -8.62%
2017 56.372.000.000 -4%
2018 52.883.000.000 -6.6%
2019 47.374.000.000 -11.63%
2020 46.878.000.000 -1.06%
2021 46.654.000.000 -0.48%
2022 46.854.000.000 0.43%
2023 47.065.000.000 0.45%
2024 50.559.000.000 6.91%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

The Procter & Gamble Company Assets
Year Assets Growth
1986 13.055.000.000
1987 13.715.000.000 4.81%
1988 14.820.000.000 7.46%
1989 16.351.000.000 9.36%
1990 18.487.000.000 11.55%
1991 20.468.000.000 9.68%
1992 24.025.000.000 14.81%
1993 24.935.000.000 3.65%
1994 25.535.000.000 2.35%
1995 28.125.000.000 9.21%
1996 27.730.000.000 -1.42%
1997 27.544.000.000 -0.68%
1998 30.966.000.000 11.05%
1999 32.113.000.000 3.57%
2000 34.194.000.000 6.09%
2001 34.387.000.000 0.56%
2002 40.776.000.000 15.67%
2003 43.706.000.000 6.7%
2004 57.048.000.000 23.39%
2005 61.527.000.000 7.28%
2006 135.695.000.000 54.66%
2007 138.014.000.000 1.68%
2008 143.992.000.000 4.15%
2009 134.833.000.000 -6.79%
2010 128.172.000.000 -5.2%
2011 138.354.000.000 7.36%
2012 132.244.000.000 -4.62%
2013 139.263.000.000 5.04%
2014 144.266.000.000 3.47%
2015 129.495.000.000 -11.41%
2016 127.136.000.000 -1.86%
2017 120.406.000.000 -5.59%
2018 118.310.000.000 -1.77%
2019 115.095.000.000 -2.79%
2020 120.700.000.000 4.64%
2021 119.307.000.000 -1.17%
2022 117.208.000.000 -1.79%
2023 120.829.000.000 3%
2024 122.370.000.000 1.26%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

The Procter & Gamble Company Liabilities
Year Liabilities Growth
1986 7.351.000.000
1987 7.975.000.000 7.82%
1988 8.483.000.000 5.99%
1989 11.136.000.000 23.82%
1990 10.969.000.000 -1.52%
1991 12.732.000.000 13.85%
1992 14.954.000.000 14.86%
1993 17.494.000.000 14.52%
1994 16.703.000.000 -4.74%
1995 17.536.000.000 4.75%
1996 16.008.000.000 -9.55%
1997 15.498.000.000 -3.29%
1998 18.730.000.000 17.26%
1999 20.055.000.000 6.61%
2000 21.907.000.000 8.45%
2001 22.377.000.000 2.1%
2002 27.070.000.000 17.34%
2003 27.520.000.000 1.64%
2004 39.770.000.000 30.8%
2005 44.050.000.000 9.72%
2006 72.787.000.000 39.48%
2007 71.254.000.000 -2.15%
2008 74.498.000.000 4.35%
2009 71.451.000.000 -4.26%
2010 66.733.000.000 -7.07%
2011 70.353.000.000 5.15%
2012 68.209.000.000 -3.14%
2013 70.554.000.000 3.32%
2014 74.290.000.000 5.03%
2015 66.445.000.000 -11.81%
2016 69.153.000.000 3.92%
2017 64.628.000.000 -7%
2018 65.427.000.000 1.22%
2019 67.516.000.000 3.09%
2020 73.822.000.000 8.54%
2021 72.653.000.000 -1.61%
2022 70.354.000.000 -3.27%
2023 73.764.000.000 4.62%
2024 71.811.000.000 -2.72%

The Procter & Gamble Company Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
35.66
Net Income per Share
6.31
Price to Earning Ratio
26.64x
Price To Sales Ratio
4.7x
POCF Ratio
19.97
PFCF Ratio
23.91
Price to Book Ratio
7.88
EV to Sales
4.99
EV Over EBITDA
18.26
EV to Operating CashFlow
21.11
EV to FreeCashFlow
25.36
Earnings Yield
0.04
FreeCashFlow Yield
0.04
Market Cap
395,13 Bil.
Enterprise Value
419,01 Bil.
Graham Number
55.05
Graham NetNet
-23.01

Income Statement Metrics

Net Income per Share
6.31
Income Quality
1.33
ROE
0.3
Return On Assets
0.12
Return On Capital Employed
0.22
Net Income per EBT
0.79
EBT Per Ebit
0.95
Ebit per Revenue
0.24
Effective Tax Rate
0.2

Margins

Sales, General, & Administrative to Revenue
-0.04
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.51
Operating Profit Margin
0.24
Pretax Profit Margin
0.22
Net Profit Margin
0.18

Dividends

Dividend Yield
0.02
Dividend Yield %
2.32
Payout Ratio
0.63
Dividend Per Share
3.89

Operating Metrics

Operating Cashflow per Share
8.42
Free CashFlow per Share
7.01
Capex to Operating CashFlow
0.17
Capex to Revenue
0.04
Capex to Depreciation
2.29
Return on Invested Capital
0.19
Return on Tangible Assets
0.25
Days Sales Outstanding
26.57
Days Payables Outstanding
137.29
Days of Inventory on Hand
62.69
Receivables Turnover
13.74
Payables Turnover
2.66
Inventory Turnover
5.82
Capex per Share
1.41

Balance Sheet

Cash per Share
4,02
Book Value per Share
21,45
Tangible Book Value per Share
-5
Shareholders Equity per Share
21.34
Interest Debt per Share
14.32
Debt to Equity
0.65
Debt to Assets
0.27
Net Debt to EBITDA
1.04
Current Ratio
0.73
Tangible Asset Value
-11,79 Bil.
Net Current Asset Value
-47,10 Bil.
Invested Capital
76459000000
Working Capital
-8,92 Bil.
Intangibles to Total Assets
0.51
Average Receivables
6,12 Bil.
Average Payables
14,53 Bil.
Average Inventory
7046500000
Debt to Market Cap
0.08

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

The Procter & Gamble Company Dividends
Year Dividends Growth
1970 2
1971 1 -100%
1972 2 0%
1973 2 0%
1974 2 0%
1975 2 50%
1976 2 0%
1977 3 0%
1978 3 0%
1979 3 33.33%
1980 4 0%
1981 4 0%
1982 4 25%
1983 2 -100%
1984 3 0%
1985 3 0%
1986 3 0%
1987 3 0%
1988 3 0%
1989 3 33.33%
1990 2 -200%
1991 2 50%
1992 2 -100%
1993 1 0%
1994 1 0%
1995 2 0%
1996 2 0%
1997 2 0%
1998 1 0%
1999 1 0%
2000 1 0%
2001 1 0%
2002 2 50%
2003 2 -100%
2004 1 0%
2005 1 0%
2006 1 0%
2007 1 0%
2008 2 0%
2009 2 0%
2010 2 0%
2011 2 50%
2012 2 0%
2013 2 0%
2014 3 0%
2015 3 0%
2016 3 0%
2017 3 0%
2018 3 0%
2019 3 0%
2020 3 33.33%
2021 3 0%
2022 4 0%
2023 4 0%
2024 4 0%

The Procter & Gamble Company Profile

About The Procter & Gamble Company

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

CEO
Mr. Jon R. Moeller
Employee
108.000
Address
One Procter & Gamble Plaza
Cincinnati, 45202

The Procter & Gamble Company Executives & BODs

The Procter & Gamble Company Executives & BODs
# Name Age
1 Mr. Jon R. Moeller
President, Chief Executive Officer & Chairman of the Board
70
2 Mr. Andre Schulten
Chief Financial Officer
70
3 Mr. Shailesh G. Jejurikar
Chief Operating Officer
70
4 Ms. R. Alexandra Keith
Chief Executive Officer of Beauty & Executive Sponsor of Corporate Sustainability
70
5 Ms. Ma. Fatima de Vera Francisco
Chief Executive Officer of Baby, Feminine & Family Care
70
6 Mr. Matthew W. Janzaruk
Senior Vice President & Chief Accounting Officer
70
7 Mr. Seth Cohen
Chief Information Officer
70
8 Mr. John T. Chevalier
Senior Vice President of Investor Relations
70
9 Ms. Susan Street Whaley
Chief Legal Officer & Secretary
70
10 Mr. Ken Patel
Chief Ethics & Compliance Officer and Chief Patent Counsel
70

The Procter & Gamble Company Competitors